Changes

Jump to: navigation, search
no edit summary
|-
| 2012 || || Report || Data released from analysis from Round 1 (2002) to Round 9 (2009) shows that the Global Fund has invested or approved US$ 430 million for activities that specifically targets people who inject drugs.<ref name="The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)"/> ||
|-
| 2013 || || Program launch || The Global Fund’s Regional Artemisinin-resistance Initiative (RAI) is launched in response to the emergence of drug-resistant malaria in the Greater Mekong region, first noted in Cambodia and Thailand and later Myanmar, Laos and Viet Nam. RAI would purchase and distribute insecticide-treated nets, diagnostic tests, and drugs.<ref>{{cite web|title=New Global Fund Grant Aims for Malaria Elimination in the Mekong|url=http://reliefweb.int/report/world/new-global-fund-grant-aims-malaria-elimination-mekong|website=http://reliefweb.int|accessdate=12 May 2017}}</ref> || [[wikipedia:Cambodia|Cambodia]], [[wikipedia:Thailand|Thailand]], [[wikipedia:Myanmar|Myanmar]], [[wikipedia:Laos|Laos]], [[wikipedia:Viet Nam|Viet Nam]]
|-
| 2013 || February || Administration || The Global Fund announces a new funding model, under which funding allocations would be determined for each eligible country based on calculations of country income and national disease burden.<ref name="The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)">{{cite journal|title=The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)|doi=10.1016/j.drugpo.2015.08.001|url=http://www.sciencedirect.com/science/article/pii/S0955395915002364|accessdate=5 May 2017}}</ref> ||
62,434
edits

Navigation menu